We are live on
!
Find out more
OFM
Omega Fund Management Portfolio holdings
AUM
$163M
1-Year Est. Return
107.06%
This Fund
S&P 500
1 Year Est. Return
+107.06%
AUM
$163M
AUM Growth
-$123M
(-43%)
Holding
11
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCAX
1
Bicara Therapeutics
BCAX
$1.4B
| $47.6M | 29.16% |
2,392,150
+187,500
|
|
||
2
Nuvation Bio
NUVB
$1.66B
| $34.7M | 21.25% |
8,081,089
|
|
||
|
BBOT
3
BridgeBio Oncology
BBOT
$598M
| $29.4M | 18.05% |
3,289,661
|
|
||
|
KMTS
4
Kestra Medical Technologies
KMTS
$1.18B
| $20.4M | 12.49% |
1,022,149
-351,442
|
|
||
|
BBNX
5
Beta Bionics
BBNX
$655M
| $13.2M | 8.08% |
1,316,183
|
|
||
6
enGene Therapeutics
ENGN
$110M
| $5.97M | 3.66% |
876,357
|
|
||
|
ALMS
7
Alumis Inc
ALMS
$2.66B
| $5.31M | 3.26% |
241,255
-411,968
|
|
||
8
Sana Biotechnology
SANA
$771M
| $2.43M | 1.49% |
843,750
|
|
||
|
IMA
9
ImageneBio Inc
IMA
$64.4M
| $2.28M | 1.4% |
455,361
|
|
||
10
Replimune Group
REPL
$712M
| $1.91M | 1.17% |
248,672
|
|
||
|
UPB
11
Upstream Bio Inc
UPB
$347M
| – | – |
-1,326,293
|
|